Provided by Tiger Trade Technology Pte. Ltd.

HANSOH PHARMA

34.000
+0.0800.24%
Volume:7.47M
Turnover:255.31M
Market Cap:206.18B
PE:31.26
High:34.640
Open:34.380
Low:33.960
Close:33.920
52wk High:43.939
52wk Low:27.882
Shares:6.06B
HK Float Shares:6.06B
Volume Ratio:0.59
T/O Rate:0.12%
Dividend:0.50
Dividend Rate:1.46%
EPS(LYR):1.088
ROE:19.40%
ROA:9.08%
PB:4.67
PE(LYR):31.26
PS:11.09

Loading ...

Goldman Sachs Boosts HANSOH PHARMA Price Target on Strong First-Half Results

Stock News
·
Aug 27

Why Hansoh Pharma Surged Over 16% After Its Earnings Report?

Deep News
·
Aug 27

Biocytogen Pharmaceuticals H1 Revenue up 51.6%

Reuters
·
Aug 27

Hansoh Pharmaceutical Group Stock Advances 16% in Hong Kong

Dow Jones
·
Aug 27

China's Hansoh Pharmaceutical Jumps Most on Record on H1 Profit Growth

Reuters
·
Aug 27

Movement Alert|HANSOH PHARMA Rises 5.73% in Regular Trading, H1 Net Profit Surges 35.8% Year-over-Year

Market Focus
·
Aug 27

Stronger Half Year Earnings And Profitability Could Be A Game Changer For Hansoh (SEHK:3692)

Simply Wall St.
·
Aug 26

Grand Pharmaceutical H1 Revenue Rises on Nuclear Medicine Demand

Reuters
·
Aug 26

HANSOH PHARMA lowers CB conversion price to HK$56.54, potential share issuance up 1.5%

Bulletin Express
·
Aug 26

Hansoh Pharmaceutical Cuts Convertible Bond Conversion Price to Hk$56.54 Per Share

Reuters
·
Aug 26

China's Zhongzhi Pharmaceutical H1 Revenue Falls 10%

Reuters
·
Aug 26

Uni-Bio Science H1 Revenue Falls 12% on Pricing Changes

Reuters
·
Aug 26

Hansoh Pharma Declares HKD 0.285 Interim Dividend for First Half of 2026

Bulletin Express
·
Aug 26

Hansoh Pharma Reports Near 36% Rise in First-Half Profit

Reuters
·
Aug 26

Hansoh Pharma Posts 35.82% Profit Surge in Interim Results

Stock News
·
Aug 26

Hansoh Pharmaceutical Group Company H1 Net Income Attributable RMB 4,257.9 Million

THOMSON REUTERS
·
Aug 26

Hansoh Pharmaceutical Group Declared Payment of an Interim Dividend of Hk$28.50 Cents Per Share for \n Six Months

THOMSON REUTERS
·
Aug 26

Hansoh Pharmaceutical Group Company H1 Revenue RMB 8,304 Million

THOMSON REUTERS
·
Aug 26

Hansoh Pharma FY26 H1 Profit Rises 35.8% to RMB 4.26 Billion; Revenue Increases 11.7% to RMB 8.3 Billion

Reuters
·
Aug 26

Hansoh Pharmaceutical Group Stock Advances 1.7% in Hong Kong

Dow Jones
·
Aug 25